Martha Stewart Embraces New Role as Champion for Chewable CBD
(Bloomberg Businessweek) -- At a party in the East Garden of the Colony Hotel in Palm Beach, Fla., on Feb. 22, the cocktails came in coconut shells bearing garnishes of gummies in three flavors. Speared onto toothpicks, the coconut, pineapple, and mango candies were the latest offerings from Martha Stewart's line of CBD chewables.
“They're delicious,” Stewart said, explaining that she'd sampled plenty of wellness gummies made by other companies and found them to be awful. She compared hers to the jellied treats served at the end of a fine French meal. “They're like pâtes de fruit. We got it down almost perfectly,” she said. “There's no aftertaste, no bitterness.”
Related: There Are Gummies to Treat Everything These Days. Do They Work?
The trio of new flavors make up the Tropical collection, which joins Citrus, Berry, and Harvest (a medley of green apple, Concord grape, and pomegranate gummies). The cost for a 30-piece jar is $35, or $1.10 per gummy.
“I wouldn't say you use these for entertaining,” said Stewart, 80, looking across the party at blond socialites chewing among lemon trees. “It's not replacing the fine chocolates on your table at the end of a fancy dinner. These are therapeutic, relaxing and useful, and nonmedicinal, which is what I go for. I'm not on a stack of medicines.”
Stewart first joined an advisory board of the product's maker, Canada-based Canopy Growth Corp., four years ago. The gummies, which were introduced in September 2020, have become a juggernaut. They're now sold in 5,000 stores, including Wegmans and Vitamin Shoppe.
The timing is good.
“It's helpful for the stress of the pandemic, and it's helpful at all times,” Stewart noted. “There are plenty of stresses these days—read the headlines.”
“What Martha has done is to make people feel safe coming into the category,” said David Klein, chief executive officer of Canopy. “Martha's made a career out of helping people live well. It ends up being like a vitamin.”
Stewart said that later this year she'll introduce “amped-up gummies with a higher dosage of CBD that will help you sleep,” among other solutions. She doesn't cook with them, she said, but she does cook with the CBD oils she offers with Canopy and suggested the lemon oil would be great to flavor a cake. At night she takes two or three drops of the CBD orange or lemon oil. “I sleep nicely,” she said.
“We have dog therapeutics, too. They are not treats, exactly, they are useful bites,” she explained. The chicken-and-cranberry chews are for calming, while the chicken-and-blueberry ones aid mobility.
Has Stewart tasted the doggy chews herself? “Of course!”
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.